Hpv-related Cervical Carcinoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2022-05-06
Clinical Trial Update: Immunogenicity AND Safety Study of the 11 Valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) [Phase 2]
Phase 2 immunogenicity and safety study of an 11-valent HPV vaccine completed.
CLINICAL_TRIALS research · 2020-08-10
Clinical Trial Update: FASTER-Tlalpan Study in Mexico: HPV Vaccination Impact on Cervical Cancer Screening Program [Phase 4]
Phase 4 trial update on HPV vaccination impact within a cervical cancer screening program in Mexico.